Daiichi Sankyo Co., Ltd.

This study tests the long-term safety and effectiveness of an experimental drug called DS-5141b in people with Duchenne muscular dystrophy (DMD). It includes 8 participants who have already completed an earlier study of the same drug. Researchers will monitor side effects and mea…

This study tests a drug called pexidartinib in 40 adults with a rare, non-cancerous joint tumor (tenosynovial giant cell tumor) that causes severe symptoms and can't be helped by surgery. The main goal is to see if the drug shrinks the tumor after 25 weeks of treatment. Participa…

This study tests a new drug, DS-1001b, in 25 people with a slow-growing brain tumor (grade II glioma) that has a specific gene change (IDH1 mutation). Participants have not had chemotherapy or radiation before. The goal is to see if the drug can shrink the tumor and how safe it i…

This early-phase study tests an experimental drug called DS-3201b in adults with non-Hodgkin lymphoma whose cancer has returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how well the drug works. About 100 participants will take p…

This study tests a drug called pexidartinib in 9 adults in Japan who have a rare, non-cancerous joint tumor (TGCT) that causes severe problems and cannot be helped by surgery. The goal is to see if the drug can shrink the tumor and improve joint movement, while checking for side …

This study tests a new drug called DS-1062a in people with advanced solid tumors, including certain lung and breast cancers that have not responded to standard treatments. It is the first time this drug is being used in humans, and the main goals are to check its safety and find …